NEOGENOMICS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Neogenomics Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Neogenomics Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $76.3M, a 17.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $76.3M +$11.1M +17.1% Dec 31, 2023 10-K 2024-02-20
Q4 2022 $65.2M +$32.2M +97.4% Dec 31, 2022 10-K 2024-02-20
Q4 2021 $33M +$30.4M +1155% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $18M Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $15.5M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $9.3M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $2.63M +$1.37M +109% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $1.26M +$938K +290% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $323K +$323K Dec 31, 2018 10-K 2020-02-28
Q4 2017 $0 Dec 31, 2017 10-K 2019-02-26
Q4 2015 $0 Dec 31, 2015 10-K 2017-03-14
Q4 2012 $1.46M +$404K +38.4% Dec 31, 2012 10-K 2013-02-21
Q4 2011 $1.05M Dec 31, 2011 10-K 2013-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.